C15H19N5O
Neat
285.35
-20°C
Room Temperature
ritlecitinib; 1792180-81-4; PF-06651600; 2-Propen-1-one, 1-[(2S, 5R)-2-methyl-5-(7H-pyrrolo[2, 3-d]pyrimidin-4-ylamino)-1-piperidinyl]-; 2OYE00PC25; PF06651600; 1-[(2S, 5R)-2-methyl-5-(7H-pyrrolo[2, 3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one; PF 06651600; 2-PROPEN-1-ONE, 1-((2S, 5R)-2-METHYL-5-(7H-PYRROLO(2, 3-D)PYRIMIDIN-4-YLAMINO)-1-PIPERIDINYL)-; 1-((2S, 5R)-2-methyl-5-(7H-pyrrolo(2, 3-d)pyrimidin-4-ylamino)piperidin-1-yl)prop-2-en-1-one; RefChem:179511; JAK3 Inhibitor PF-06651600; 1-((2S, 5R)-2-methyl-5-((7H-pyrrolo(2, 3-d)pyrimidin-4-yl)amino)piperidin-1-yl)prop-2-en-1-one; 815-269-7; 1-((2S, 5R)-5-((7H-Pyrrolo[2 and 3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one; PF-06651600 free base; MFCD30343868; ritlecitinibum; Ritlecitinib?; MFCD31697544
1-[(2S, 5R)-2-methyl-5-(7H-pyrrolo[2 and 3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one
InChI=1S/C15H19N5O/c1-3-13(21)20-8-11(5-4-10(20)2)19-15-12-6-7-16-14(12)17-9-18-15/h3,6-7,9-11H,1,4-5,8H2,2H3,(H2,16,17,18,19)/t10-,11+/m0/s1